文献速递儿童神经与发育行为

脐带血输注治疗儿童孤独症谱系障碍的II期随机临床试验

A Phase II Randomized Clinical Trial of the Safety and Efficacy of Intravenous Umbilical Cord Blood Infusion for Treatment of Children with Autism Spectrum Disorder.
PubMed 文献 · J Pediatr · 2020-05-19

这项前瞻性、随机、安慰剂对照、双盲研究纳入180名2-7岁孤独症谱系障碍(ASD)儿童,比较单次静脉输注自体或异体脐带血(CB)与安慰剂的疗效。结果显示CB输注安全且耐受良好,但整体样本中未发现CB对社交沟通(VABS-3社会化领域)或次要结局(孤独症症状、词汇)有改善作用,也未发现不同CB类型的总体差异效应。在无智力障碍的亚组中,异体CB与临床医生评定的改善比例较高相关,但改善的OR不显著,且该亚组在沟通技能和探索性指标上显示显著改善。

要点

  • 单次脐带血输注在ASD儿童中安全且耐受良好,但未改善整体社交沟通或孤独症症状。
  • 无智力障碍亚组中,异体CB与临床改善比例较高相关,但OR不显著。
  • 无智力障碍亚组接受CB后沟通技能及注意、脑电功率等探索性指标有显著改善。

核心结论

  • 单次脐带血输注整体上与社交技能改善或孤独症症状减轻无关。
  • 需更多研究确定脐带血输注是否对部分ASD儿童有效。

研究设计与样本

  • 前瞻性、随机、安慰剂对照、双盲研究纳入180名2-7岁ASD儿童。
  • 儿童接受单次静脉自体脐带血(n=56)、异体脐带血(n=63)或安慰剂(n=61),输注后6个月评估。

主要发现

  • 脐带血输注安全且耐受良好。
  • 整体样本分析未发现脐带血与主要结局(VABS-3社会化领域)或次要结局(孤独症症状、词汇)改善相关。
  • 无整体证据表明不同脐带血类型存在差异效应。
  • 无智力障碍亚组中,异体(而非自体)脐带血与临床医生评定的改善比例较高相关,但改善的OR不显著。
  • 无智力障碍亚组接受脐带血后沟通技能(VABS-3沟通领域)及探索性指标(玩具注意、持续注意眼动追踪、α和β脑电功率增加)有显著改善。

关键数值与推荐

  • 主要结局为VABS-3社会化领域评分。
  • 次要结局包括孤独症症状(Pervasive Developmental Disorder Behavior Inventory)和词汇(Expressive One-Word Picture Vocabulary Test)。
  • 亚组分析使用临床医生评定的Clinical Global Impression-Improvement量表。

临床怎么用

  • 目前证据不支持将单次脐带血输注作为ASD儿童的常规治疗。
  • 对于无智力障碍的ASD儿童,脐带血输注的潜在获益需进一步研究验证。

局限性

  • 亚组分析中改善的OR不显著,结果需谨慎解读。
  • 探索性指标(眼动追踪、脑电功率)的临床意义尚不明确。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate whether umbilical cord blood (CB) infusion is safe and associated with improved social and communication abilities in children with autism spectrum disorder (ASD). STUDY DESIGN: This prospective, randomized, placebo-controlled, double-blind study included 180 children with ASD, aged 2-7 years, who received a single intravenous autologous (n = 56) or allogeneic (n = 63) CB infusion vs placebo (n = 61) and were evaluated at 6 months postinfusion. RESULTS: CB infusion was safe and well tolerated. Analysis of the entire sample showed no evidence that CB was associated with improvements in the primary outcome, social communication (Vineland Adaptive Behavior Scales-3 [VABS-3] Socialization Domain), or the secondary outcomes, autism symptoms (Pervasive Developmental Disorder Behavior Inventory) and vocabulary (Expressive One-Word Picture Vocabulary Test). There was also no overall evidence of differential effects by type of CB infused. In a subanalysis of children without intellectual disability (ID), allogeneic, but not autologous, CB was associated with improvement in a larger percentage of children on the clinician-rated Clinical Global Impression-Improvement scale, but the OR for improvement was not significant. Children without ID treated with CB showed significant improvements in communication skills (VABS-3 Communication Domain), and exploratory measures including attention to toys and sustained attention (eye-tracking) and increased alpha and beta electroencephalographic power. CONCLUSIONS: Overall, a single infusion of CB was not associated with improved socialization skills or reduced autism symptoms. More research is warranted to determine whether CB infusion is an effective treatment for some children with ASD.

来源:J Pediatr,查看原文。版权归原作者所有。

引用

  1. Dawson G, Sun JM, Baker J, et al. A Phase II Randomized Clinical Trial of the Safety and Efficacy of Intravenous Umbilical Cord Blood Infusion for Treatment of Children with Autism Spectrum Disorder. J Pediatr. 2020. PMID: 32444220. doi:10.1016/j.jpeds.2020.03.011

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。